Trial Profile

Prospective Phase IV Clinical Trial on Effectiveness of Rebif Treatment of CIS and RMS Patients in Romania Using Electronic Device RebiSmart

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 14 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Interferon beta-1a (Primary)
Indications Demyelinating disorders; Multiple sclerosis
Focus Therapeutic Use
Acronyms PROCEED
Sponsors Merck KGaA

Most Recent Events

09 Mar 2017 Status changed from active, no longer recruiting to completed.
07 Dec 2015 Planned End Date changed from 1 Apr 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.
07 Dec 2015 Planned primary completion date changed from 1 Apr 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com